Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Oral levofloxacin 600 mg and 300 mg daily doses in difficult-to-treat respiratory infections.

× No keyword cloud information.

1 in total

Review 1. Ofloxacin.

Authors: A R Tunkel; W M Scheld
Journal: Infect Control Hosp Epidemiol Date: 1991-09 Impact factor: 3.254

1 in total

5 in total

1. In vitro activity of levofloxacin against a selected group of anaerobic bacteria isolated from skin and soft tissue infections.

Authors: H M Wexler; E Molitoris; D Molitoris; S M Finegold
Journal: Antimicrob Agents Chemother Date: 1998-04 Impact factor: 5.191

2. The new fluoroquinolones: A critical review.

Authors: G G Zhanel; A Walkty; L Vercaigne; J A Karlowsky; J Embil; A S Gin; D J Hoban
Journal: Can J Infect Dis Date: 1999-05

Review 3. A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections.

Authors: S J Martin; R Jung; C G Garvin
Journal: Drug Saf Date: 2001 Impact factor: 5.606

Review 4. Prolonged antibiotics for non-cystic fibrosis bronchiectasis in children and adults.

Authors: Khin Hnin; Chau Nguyen; Kristin V Carson; David J Evans; Michael Greenstone; Brian J Smith
Journal: Cochrane Database Syst Rev Date: 2015-08-13

Review 5. Continuous versus intermittent antibiotics for bronchiectasis.

Authors: Tim Donovan; Lambert M Felix; James D Chalmers; Stephen J Milan; Alexander G Mathioudakis; Sally Spencer
Journal: Cochrane Database Syst Rev Date: 2018-06-03

5 in total